16 results
IDSA Recommendations for the Treatment of Clostridium difficile Infection in Adults
Source: https://doi.org/10.1093/cid/cix1085

#Management #Clostridium #CDifficile #IDSA2017 #Guidelines
IDSA Recommendations ... difficile Infection ... doi.org/10.1093/cid ... /cix1085 #Management ... #Clostridium #CDifficile
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table ...  1. ... difficile Infection ... #Clostridium #CDifficile
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Therapy for Treating Clostridium ... difficile Infection ... (CDI): • Vancomycin ... #management #opportunistic
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Guidelines - Table ... difficile Infection ... in Children #Management ... #CDifficile #IDSA2017
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... difficile infection ... #Pharmacology #Management ... #CDifficile #IDSA2017
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Infection (CDI) ... Epidemiology: • #1 ... 10 mg/kg IV x 1 ... IDSA 2021 CDI ... #Clostridium #Infection
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... patients with CD4 ... opportunistic #infections ... #HIVAIDS #management
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... ART to maintain CD4 ... ) for 1–4 doses ... Cytomegalovirus #CMV #IDSA ... #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... mg/kg on days 1– ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections